COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia.
作者信息
Wu Yinlian, Lin Heng, Xie Qiang, Chen Qun, Huang Yanfang, Zhu Yueyong, Chen Lizhou
机构信息
Department of Liver Research Center, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Department of Oncology, Fuzhou Pulmonary Hospital, Fuzhou, China.
出版信息
Br J Haematol. 2020 Jul;190(1):e13-e15. doi: 10.1111/bjh.16799. Epub 2020 Jun 2.
Abstract
摘要
相似文献
1
COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia.一名患有既往急性淋巴细胞白血病患者的新型冠状病毒肺炎
Br J Haematol. 2020 Jul;190(1):e13-e15. doi: 10.1111/bjh.16799. Epub 2020 Jun 2.
2
Lopinavir pharmacokinetics in COVID-19 patients.洛匹那韦在新冠肺炎患者中的药代动力学。
J Antimicrob Chemother. 2020 Sep 1;75(9):2702-2704. doi: 10.1093/jac/dkaa195.
3
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.利托那韦和洛匹那韦在一名感染新型冠状病毒肺炎患者中诱导红细胞凋亡。
Blood. 2020 Aug 13;136(7):915. doi: 10.1182/blood.2020006228.
4
Imatinib for COVID-19: A case report.伊马替尼治疗新型冠状病毒肺炎：一例病例报告。
Clin Immunol. 2020 Sep;218:108518. doi: 10.1016/j.clim.2020.108518. Epub 2020 Jun 27.
5
Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression.一名患有急性髓系白血病且因治疗导致严重免疫抑制的1岁女童新冠病毒病2019的良好转归。
Br J Haematol. 2020 Jun;189(6):e222-e224. doi: 10.1111/bjh.16781. Epub 2020 May 19.
6
BET 1: Lopinavir-ritonavir and COVID-19.赌注1：洛匹那韦-利托那韦与2019冠状病毒病
Emerg Med J. 2020 Jul;37(7):450-451. doi: 10.1136/emermed-2020-210221.2.
7
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.洛匹那韦/利托那韦口服液治疗 ICU 机械通气 COVID-19 患者的药代动力学。
J Antimicrob Chemother. 2020 Sep 1;75(9):2657-2660. doi: 10.1093/jac/dkaa261.
8
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect.在新冠肺炎患者中停用洛匹那韦/利托那韦：药物相互作用效应的持续时间。
J Antimicrob Chemother. 2020 Oct 1;75(10):3084-3086. doi: 10.1093/jac/dkaa253.
9
Presumed COVID-19 index case on diamond princess cruise ship and evacuees to Hong Kong.钻石公主号邮轮上的疑似新冠肺炎确诊病例及撤离至香港的人员。
J Travel Med. 2020 Aug 20;27(5). doi: 10.1093/jtm/taaa073.
10
Treating COVID-19 with Chloroquine.用氯喹治疗新型冠状病毒肺炎。
J Mol Cell Biol. 2020 May 18;12(4):322-325. doi: 10.1093/jmcb/mjaa014.
引用本文的文献
1
Stability of a discrete HTLV-1/SARS-CoV-2 dual infection model.离散型人类嗜T淋巴细胞病毒1型/严重急性呼吸综合征冠状病毒2型双重感染模型的稳定性
Heliyon. 2024 Mar 18;10(7):e28178. doi: 10.1016/j.heliyon.2024.e28178. eCollection 2024 Apr 15.
2
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report.大流行15个月期间急性淋巴细胞白血病患者的COVID-19感染情况。一份校园急性淋巴细胞白血病研究报告。
Haematologica. 2022 Aug 1;107(8):1955-1959. doi: 10.3324/haematol.2021.280289.
3
Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient.CT值在区分免疫功能低下患者的新冠病毒再次感染与病毒长期脱落中的作用。
BMJ Case Rep. 2021 Jul 27;14(7):e243692. doi: 10.1136/bcr-2021-243692.
4
SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report.异基因造血干细胞移植期间血液系统疾病患者的新型冠状病毒2型感染：一例双病例报告
Clin Case Rep. 2021 Jul 19;9(7):e04439. doi: 10.1002/ccr3.4439. eCollection 2021 Jul.
5
The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review.《COVID-19 大流行期间的抗生素处方谱：系统文献回顾》。
Microb Drug Resist. 2021 Dec;27(12):1705-1725. doi: 10.1089/mdr.2020.0619. Epub 2021 Jun 1.
6
Weathering the storm: COVID-19 infection in patients with hematological malignancies.安然度过风暴：血液系统恶性肿瘤患者的 COVID-19 感染。
J Zhejiang Univ Sci B. 2020;21(12):921-939. doi: 10.1631/jzus.B2000423.
7
The Looming Effects of Estrogen in Covid-19: A Rocky Rollout.雌激素在新冠病毒肺炎中的潜在影响：艰难的推广
Front Nutr. 2021 Mar 18;8:649128. doi: 10.3389/fnut.2021.649128. eCollection 2021.
8
The impact of the SARS-CoV-2 infection, with special reference to the hematological setting.SARS-CoV-2 感染的影响，特别参考血液学方面。
J Med Virol. 2021 Jan;93(1):223-233. doi: 10.1002/jmv.26197. Epub 2020 Jul 11.
9
Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs?发展中国家的浆细胞骨髓瘤治疗：是否每个人都需要最新的药物？
Acta Haematol. 2020;143(6):513-515. doi: 10.1159/000505991. Epub 2020 Mar 10.
本文引用的文献
1
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis.淋巴细胞减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：系统评价和荟萃分析。
Int J Infect Dis. 2020 Jul;96:131-135. doi: 10.1016/j.ijid.2020.04.086. Epub 2020 May 4.
2
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.COPD 和吸烟史对 COVID-19 严重程度的影响：系统评价和荟萃分析。
J Med Virol. 2020 Oct;92(10):1915-1921. doi: 10.1002/jmv.25889. Epub 2020 May 17.
3
COVID-19 in posttransplant patients-report of 2 cases.COVID-19 在后移植患者中的报告-2 例。
Am J Transplant. 2020 Jul;20(7):1879-1881. doi: 10.1111/ajt.15896. Epub 2020 Apr 17.
4
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
5
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
6
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
7
Emerging coronaviruses: Genome structure, replication, and pathogenesis.新兴冠状病毒：基因组结构、复制和发病机制。
J Med Virol. 2020 Apr;92(4):418-423. doi: 10.1002/jmv.25681. Epub 2020 Feb 7.
8
Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle.中国武汉不明原因肺炎疫情：谜团与奇迹
J Med Virol. 2020 Apr;92(4):401-402. doi: 10.1002/jmv.25678. Epub 2020 Feb 12.
Zotero 插件